Yakult Reduces Oncology Portfolio As It Looks Towards Microbiome

Multiple Products Transferred

Yakult plans to transfer Elplat’s sales and distribution operations to Takata by April 2024.
Yakult plans to transfer cancer drug Elplat to Takata by April 2024 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia